Novavax breaks another pledge for its Covid-19 vaccine. And the US is reportedly fretting about global goals now
We’re talking weeks here, not months. — Stanley Erck, CEO of Novavax, to analysts on August 5.
In the U.S., we expect to submit our complete regulatory package to the FDA before the end of this year. — Erck on November 4.
Novavax expects to submit a request for EUA for the vaccine in the U.S. in one month… — Novavax statement on December 31.
You can add one more broken promise from Novavax $NVAX on its Covid-19 vaccine application to the FDA.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 142,600+ biopharma pros reading Endpoints daily — and it's free.